Northeast Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $235K | Hold |
3,405
| – | – | 0.01% | 173 |
|
2025
Q1 | $236K | Hold |
3,405
| – | – | 0.01% | 169 |
|
2024
Q4 | $293K | Sell |
3,405
-155
| -4% | -$13.3K | 0.01% | 161 |
|
2024
Q3 | $424K | Hold |
3,560
| – | – | 0.02% | 143 |
|
2024
Q2 | $508K | Hold |
3,560
| – | – | 0.02% | 134 |
|
2024
Q1 | $457K | Hold |
3,560
| – | – | 0.02% | 140 |
|
2023
Q4 | $368K | Buy |
3,560
+300
| +9% | +$31K | 0.02% | 148 |
|
2023
Q3 | $296K | Hold |
3,260
| – | – | 0.02% | 159 |
|
2023
Q2 | $264K | Buy |
+3,260
| New | +$264K | 0.01% | 164 |
|
2022
Q2 | – | Sell |
-4,060
| Closed | -$225K | – | 197 |
|
2022
Q1 | $225K | Hold |
4,060
| – | – | 0.01% | 195 |
|
2021
Q4 | $227K | Buy |
+4,060
| New | +$227K | 0.01% | 195 |
|
2016
Q4 | – | Sell |
-80,214
| Closed | -$1.67M | – | 162 |
|
2016
Q3 | $1.67M | Sell |
80,214
-12,606
| -14% | -$262K | 0.17% | 83 |
|
2016
Q2 | $2.5M | Sell |
92,820
-69,824
| -43% | -$1.88M | 0.25% | 71 |
|
2016
Q1 | $4.41M | Sell |
162,644
-6,298
| -4% | -$171K | 0.45% | 60 |
|
2015
Q4 | $4.91M | Buy |
168,942
+2,382
| +1% | +$69.2K | 0.51% | 56 |
|
2015
Q3 | $4.52M | Buy |
166,560
+2,656
| +2% | +$72K | 0.49% | 60 |
|
2015
Q2 | $4.49M | Sell |
163,904
-2,040
| -1% | -$55.9K | 0.45% | 61 |
|
2015
Q1 | $4.43M | Sell |
165,944
-10,818
| -6% | -$289K | 0.43% | 60 |
|
2014
Q4 | $3.74M | Sell |
176,762
-10,836
| -6% | -$229K | 0.37% | 64 |
|
2014
Q3 | $4.47M | Sell |
187,598
-5,292
| -3% | -$126K | 0.45% | 61 |
|
2014
Q2 | $4.46M | Buy |
192,890
+11,252
| +6% | +$260K | 0.45% | 60 |
|
2014
Q1 | $4.15M | Buy |
181,638
+57,038
| +46% | +$1.3M | 0.44% | 63 |
|
2013
Q4 | $2.3M | Buy |
124,600
+64,330
| +107% | +$1.19M | 0.26% | 74 |
|
2013
Q3 | $1.02M | Buy |
+60,270
| New | +$1.02M | 0.12% | 95 |
|